BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 6, 2009
View Archived Issues
The nAChR agonist WYE-103914 demonstrates efficacy in rodent cognition models
Read More
GF-015535-00 shows safety and potent sedative/hypnotic effects in vivo
Read More
SCY-635 shows synergistic antiviral activity in combination with anti-HCV agents in vitro
Read More
Lactin-V reduces recurrent urinary tract infection in phase II study
Read More
Significant weight loss, diabetes onset delay with liraglutide in obese subjects
Read More
Study in over 4,000 infants reveals immunogenicity of Hib-MenCY-TT vaccine
Read More
Germany approves CureVac's CV-9103 prostate cancer vaccine for phase IIa trial
Read More
FDA grants orphan drug designation to TNFerade
Read More
Aerovance completes patient enrollment in phase IIb Aerovant trial in asthma
Read More
Enobia Pharma initiates phase II trial of ENB-0040 in hypophosphatasia
Read More
Arpida confirms definitive agreement for intended merger with Evolva
Read More
Comparable immunogenicity of VRC DNA and rAD5 AIDS vaccines reported in healthy adults
Read More
Clinical evaluation of HIV antigen lipopeptide vaccines disclosed at AIDS Vaccine 2009
Read More
Amgen reports overall survival results for Vectibix in metastatic colorectal cancer
Read More
Acceleron initiates first-in-human study of ACE-041 in cancer patients
Read More
Aeolus' AEOL-10150 protects lungs against chlorine gas exposure in animal studies
Read More
Daiichi Sankyo launches new phase III trial of CS-8958 for flu prevention
Read More
FDA approves protocol amendment to SPA for phase III Lucanix study in NSCLC
Read More
Glenmark synthesizes novel TRPV3 receptor antagonists as analgesic agents
Read More
Flamel Technologies enters licensing agreement with Pfizer
Read More
New 11beta-HSD1 inhibitors claimed by sanofi-aventis for the treatment of type 2 diabetes
Read More
Banyu describes novel RSK1 inhibitors as oncolytics
Read More
Novel PD agent Lu 02-750 enters Lundbeck's development pipeline
Read More
Merck & Co. and Schering-Plough have completed their merger
Read More
Agennix acquires GPC Biotech
Read More
Novartis' influenza A(H1N1) vaccine Celtura approved in Germany
Read More
